Skip to main content
SpringerLink
Log in

Continuous ambulatory peritoneal dialysis

  • Chapter
Textbook of Peritoneal Dialysis

Abstract

Continuous ambulatory peritoneal dialysis (CAPD) was introduced as a new technique for dialysis in 1976 [1]. Until that time intermittent peritoneal dialysis (IPD) was the only alternative to chronic intermittent haemodialysis. Despite safe indwelling catheters and the development of more or less sophisticated machines for automatic peritoneal dialysis, favouring IPD as a treatment at home, peritoneal dialysis remained far behind haemodialysis in the treatment of chronic renal failure. Under usual operating conditions (one or two 2-litre exchanges per hour) the urea clearance is only 20 ml/ min or less. Because of this low clearance, on a weekly basis 30–50 dialysis hours were necessary to equal 12 h per week of haemodialysis [2]. Furthermore, protein loss during dialysis and peritonitis were regarded as a major drawback of IPD. In 1977 all over the world a total of 789 patients on IPD could be traced [3]. A publication of the National Institutes of Health in 1978 showed that less than 3% of patients with dialysis were managed on IPD [4].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Popovich RP, Moncrief JW, Decherd JF et al. The definition of a novel portable—wearable equilibrium peritoneal technique. Am Soc Artif Intern Organs 1976; 5: 64 (abstract).

    Google Scholar 

  2. Moncrief JW, Popovich RP, Dombros NV et al. Continuous ambulatory peritoneal dialysis. In: Gokal R, Nolph KD, eds. Peritoneal Dialysis. Dordrecht: Kluwer, 1994, pp. 357–97.

    Google Scholar 

  3. Boen ST. Overview and history of peritoneal dialysis. Dial Transplant 1977; 6: 12–18.

    Google Scholar 

  4. Wineman RJ. End-stage renal decease. Dial Transplant 1978; 7: 1034.

    Google Scholar 

  5. Popovich RP, Moncrief JW, Nolph KD et al. Continuous ambulatory peritoneal dialysis. Ann Intern Med 1978; 88: 449–56.

    PubMed  CAS  Google Scholar 

  6. Moncrief JW. Continuous ambulatory peritoneal dialysis. Dial Transplant 1978; 8: 809–10.

    Google Scholar 

  7. Moncrief JW, Nolph KD, Rubin J. Additional experience with continuous ambulatory peritoneal dialysis (CAPD). Trans Am Soc Artif Intern Organs 1978; 24: 476–83.

    PubMed  CAS  Google Scholar 

  8. Nolph KD, Popovich RP, Moncrief JW. Theoretical and practical implications of continuous ambulatory peritoneal dialysis. Nephron 1978; 21: 117–22.

    PubMed  CAS  Google Scholar 

  9. Oreopoulos DG, Robson N, Izatt S. A simple and safe technique for continuous ambulatory peritoneal dialysis (CAPD). Trans Am Soc Artif Intern Organs 1978; 24: 484–7.

    PubMed  CAS  Google Scholar 

  10. Oreopoulos DG. Continuous ambulatory peritoneal dialysis in Canada. Can Med Assoc J 1979; 120: 16.

    PubMed  CAS  Google Scholar 

  11. Moncrief JW, Popovich RP, Nolph KD et al. Clinical experience with continuous ambulatory peritoneal dialysis. ASAIO J 1979; 2: 114–19.

    Google Scholar 

  12. Nolph KD. Peritoneal clearances. J Lab Clin Med 1979; 94: 519–25.

    PubMed  CAS  Google Scholar 

  13. Rubin J, Nolph K, Arfania D et al. Follow-up of peritoneal clearances in patients undergoing continuous ambulatory peritoneal dialysis. Kidney Int 1979; 16: 619–23.

    PubMed  CAS  Google Scholar 

  14. Oreopoulos DG Robson M, Faller B et al. Continuous ambulatory peritoneal dialysis: a new era in the treatment of chronic renal failure. Clin Nephrol 1979; 11: 125–8.

    Google Scholar 

  15. Oreopoulos DG. The coming of age of continuous ambulatory peritoneal dialysis (CAPD). Dial Transplant 1979; 8: 460.

    Google Scholar 

  16. Popovich RP, Hlavinka DJ, Bomar JB et al. Consequences of physiological resistances on metabolite removal from the patient-artificial kidney system. Trans Am Soc Artif Intern Organs 1975; 21: 108–15.

    PubMed  CAS  Google Scholar 

  17. Gotch FA, Sargent JA. A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int 1985; 28: 526–34.

    PubMed  CAS  Google Scholar 

  18. Watson PE, Watson ID, Batt RD. Total body water volumes for adult males and females estimated from simple anthropometric measurements. Am J Clin Nutr 1980; 33: 27–39.

    PubMed  CAS  Google Scholar 

  19. Keshaviah PR, Nolph KD, van Stone JC. The peak concentration hypothesis: a urea kinetic approach to comparing the adequacy of continuous ambulatory peritoneal dialysis (CAPD) and hemodialysis. Petit Dial Int 1989; 9: 257–60.

    CAS  Google Scholar 

  20. Lysaght MJ, Pollock CA, Hallet MD et al. The relevance of urea kinetic modelling to CAPD. Trans Am Soc Artif Intern Organs 1989; 35: 784–90.

    CAS  Google Scholar 

  21. Keshaviah PR, Nolph KD, Prowant B et al. Defining adequacy of CAPD with urea kinetics. Adv Petit Dial 1990; 6: 173–7.

    CAS  Google Scholar 

  22. Gotch FA. Application of urea kinetic modeling to adequacy of CAPD therapy. Adv Petit Dial 1990; 6: 178–80.

    CAS  Google Scholar 

  23. Keshaviah P. Urea kinetic and middle molecule approaches to assessing the adequacy of hemodialysis and CAPD. Kidney Int 1990; 43: S28–38.

    Google Scholar 

  24. Gotch FA. The application of urea kinetic modeling to CAPD. In: La Greca G, Ronco C, Feriani M et al.,eds. Peritoneal Dialysis. Milan: Wichtig, 1991, pp. 47–51.

    Google Scholar 

  25. Tzamaloukas AH, Murata GH, Malhotra D et al. The minimal dose of dialysis required for a target KT/V in continuous peritoneal dialysis. Clin Nephrol 1995; 44: 316–21.

    PubMed  CAS  Google Scholar 

  26. NKF-DOQI Committee. Adequate dose of peritoneal dialysis. Am J Kidney Dis 1997; 30 (suppl. 2): S86–92.

    Google Scholar 

  27. Twardowski ZJ, Nolph KD, Khanna R et al. Peritoneal equilibrium test. Petit Dial Bull 1987; 7: 138–47.

    Google Scholar 

  28. Twardowski ZJ. Clinical value of standardized equilibrium tests in CAPD patients. Blood Purif 1989; 7: 95–108.

    PubMed  CAS  Google Scholar 

  29. Krediet RT, Boeschoten EW, Zuijderhoudt FMJ et al. Simple assessment of the efficacy of peritoneal transport in continuous ambulatory peritoneal dialysis patients. Blood Purif 1986; 4: 194–203.

    PubMed  CAS  Google Scholar 

  30. Waniewski J, Werynski A, Heimbürger O et al. Simple models for description of small-solute transport in peritoneal dialysis. Blood Purif 1991; 9: 129–41.

    PubMed  CAS  Google Scholar 

  31. Pannekeet MM, Imholz ALT, Struijk DG et al. The standard peritoneal permeability analysis: a tool for the assessment of peritoneal permeability characteristics in CAPD patients. Kidney Int 1995; 48: 866–75.

    PubMed  CAS  Google Scholar 

  32. Struijk DG, Krediet RT, Koomen GCM et al. Measurement of peritoneal transport for low molecular weight solutes; which test should be used? Nephrol Dial Transplant 1990; 5: 721.

    Google Scholar 

  33. Heimbürger O, Waniewski J, Werynski A et al. Dialysate to plasma solute concentration (D/P) versus peritoneal transport parameters in CAPD. Nephrol Dial Transplant 1994; 9: 47–59.

    PubMed  Google Scholar 

  34. Bergström J. Serum middle molecules and continuous ambulatory peritoneal dialysis. Petit Dial Bull 1982; 2: 59–61.

    Google Scholar 

  35. Lamperi S, Carozzi S, Icardi A. Improvement of erythropoiesis in uremic patients on CAPD. Int J Artif Organs 1983; 6: 191–4.

    PubMed  CAS  Google Scholar 

  36. Arends JP, Krediet RT, Boeschoten EW et al. Improvement of bleeding time, platelet aggregation and platelet count during CAPD treatment. Proc EDTA 1981; 18: 280–5.

    CAS  Google Scholar 

  37. Twardowski ZJ, Khanna R, Nolph KD. Osmotic agents and ultrafiltration in peritoneal dialysis. Nephron 1986; 42: 93–101.

    PubMed  CAS  Google Scholar 

  38. Krediet RT, Boeschoten EW, Zuijderhoudt FMJ et al. The relationship between peritoneal glucose absorption and body fluid loss by ultrafiltration during continuous ambulatory peritoneal dialysis. Clin Nephrol 1987; 27: 51–5.

    PubMed  CAS  Google Scholar 

  39. Imholz ALT, Koomen GCM, Struijk DG et al. Effect of dialysate osmolarity on the transport of low molecular weight solutes and proteins during CAPD. Kidney Int 1993; 43: 1339–46.

    PubMed  CAS  Google Scholar 

  40. Leypoldt JK, Mistry CD. Ultrafiltration in peritoneal dialysis. In: Gokal R, Nolph KD, eds. Peritoneal Dialysis. Dordrecht: Kluwer, 1994, pp. 135–61.

    Google Scholar 

  41. Nolph KD, Mactier RA, Khanna R et al. The kinetics of ultrafiltration during peritoneal dialysis: the role of lymphatics. Kidney Int 1987; 32: 219–26.

    PubMed  CAS  Google Scholar 

  42. Struijk DG, Koomen GCM, Krediet RT et al. Indirect measurement of lymphatic absorption in CAPD patients by the disappearance of dextran 70 is not influenced by trapping. Kidney Int 1992; 41: 1668–75.

    PubMed  CAS  Google Scholar 

  43. Mactier RA, Khanna R, Twardowski ZJ et al. Contribution of lymphatic absorption to loss of ultrafiltration and solute clearance in continuous ambulatory peritoneal dialysis. J Clin Invest 1987; 80: 1311–16.

    PubMed  CAS  Google Scholar 

  44. Imholz ALT, Koomen GCM, Struijk DG et al. The effect of an increased intraperitoneal pressure of fluid and solute transport during CAPD. Kidney Int 1993; 44: 1078–85.

    PubMed  CAS  Google Scholar 

  45. Imholz ALT, Koomen GCM, Vorh WJ et al. Day-to-day variability of fluid and solute transport in upright and recumbent positions during CAPD. Nephrol Dial Transplant 1998; 13: 146–53.

    PubMed  CAS  Google Scholar 

  46. Hirszel P, Lameire N, Bogaert M. Pharmacologic alterations of peritoneal transport rates and pharmacokinetics of the peritoneum. In: Gokal R, Nolph KD, eds. Peritoneal Dialysis. Dordrecht: Kluwer, 1994, pp. 161–234.

    Google Scholar 

  47. Zemel D, Koomen GCM, Hart AAM et al. Relationship of TNFa, interleukin-6 and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis. J Lab Clin Med 1993; 122: 686–96.

    PubMed  CAS  Google Scholar 

  48. Tenckhoff H, Schechter H. A bacteriological safe peritoneal access device. Trans Am Soc Artif Intern Organs 1968; 14: 181–6.

    PubMed  CAS  Google Scholar 

  49. Twardowski ZJ, Nolph KD, Khanna R et al. The need for `swan-neck’ permanently bent arcuate peritoneal catheter. Petit Dial Bull 1985; 5: 219–23.

    Google Scholar 

  50. Swartz R, Messana J, Rocher L et al. The curled catheter: dependable device for percutaneous peritoneal access. Petit Dial Int 1990; 10: 231–5.

    CAS  Google Scholar 

  51. Ash SR. Chronic peritoneal dialysis catheters: effects of catheter design, materials and location. Semin Dial 1990; 30: 39–40.

    Google Scholar 

  52. Cruz C. Cruz catheter: implantation technique and clinical results. Petit Dial Int 1994; 14: S59–63.

    Google Scholar 

  53. Gokal A, Ash SR, Helfrich GB et al. Peritoneal catheters and exit-site practices: toward optimum peritoneal access. Petit Dial Int 1993; 13: 29–39.

    CAS  Google Scholar 

  54. Ogden DA, Bernavente G, Wheeler D et al. Experience with the right angle GORE-TEX®; peritoneal dialysis catheter. In: Khanna R, Nolph KD, Prowant B et al.,eds. Advances in Continuous Ambulatory Peritoneal Dialysis. Toronto: Peritoneal Dialysis Bulletin Inc., 1986, pp. 155–9.

    Google Scholar 

  55. Pommer W, Brauner M, Westphale HJ et al. The effect of a silver device in preventing catheter-related infections in peritoneal dialysis patients: Silver Ring Prophylaxis at the Catheter Exit Study. Am J Kidney Dis 1998; 32: 752–60.

    PubMed  CAS  Google Scholar 

  56. Lye WC, Lee EJC, Tan CC. Prophylactic antibiotics in the insertion of Tenckhoff catheters. Scand J Urol Nephrol 1992; 26: 177–80.

    PubMed  CAS  Google Scholar 

  57. Port FK, Held PJ, Nolph KD et al. Risk of peritonitis and technique failure by CAPD connection technique: a national study. Kidney Int 1992; 42: 967–74.

    PubMed  CAS  Google Scholar 

  58. Maiorca R, Cataluppi A, Cancarini GC et al. Prospective controlled trial of a Y-connector and disinfectant to prevent peritonitis in continuous ambulatory peritoneal dialysis. Lancet 1983; 2: 642–4.

    PubMed  CAS  Google Scholar 

  59. Boen ST. Peritoneal dialysis. MD thesis. Van Gorcum and Comp., Assen, 1959.

    Google Scholar 

  60. Boen ST. Kinetics of peritoneal dialysis. Medicine 1961; 4: 243–87.

    Google Scholar 

  61. Dobbie JW. Pathogenesis of peritoneal fibrosis syndromes (sclerosing peritonitis) in peritoneal dialysis. Petit Dial Int 1992; 12: 14–27.

    CAS  Google Scholar 

  62. Yamada K, Miyakassa Y, Hamaguchi K et al. Immunohistochemical study of human advanced glycosylation end-products (AGE) in chronic renal failure. Clin Nephrol 1994; 42: 354–61.

    PubMed  CAS  Google Scholar 

  63. Hendriks SMEM, Ho-dac-Pannekeet MM, van Gulik TM et al. Peritoneal sclerosis in peritoneal dialysis patients: analysis of clinical presentation, risk factors and peritoneal transport kinetics. Petit Dial Int 1997; 17: 136–43.

    CAS  Google Scholar 

  64. Faller B, Aparicio M, Faict D et al. Clinical evaluation of an optimized 1.1% amino-acid solution for peritoneal dialysis. Nephrol Dial Transplant 1995; 10: 1432–7.

    PubMed  CAS  Google Scholar 

  65. Kopple JD, Bernard D, Massana J et al. Treatment of malnourished CAPD patients with an amino acid based dialysate. Kidney Int 1995; 47: 1148–57.

    PubMed  CAS  Google Scholar 

  66. Matthys E, Dolkart R, Lameire N. Extended use of a glycerol-containing dialysate in diabetic CAPD patients. Petit Dial Bull 1987; 7: 10–15.

    Google Scholar 

  67. Matthys E, Dolkart R, Lameire N. Potential hazards of glycerol dialysate in diabetic CAPD patients. Petit Dial Bull 1987; 7: 16–19.

    Google Scholar 

  68. Mistry CD, Gokal R. Single daily overnight (12-h dwell) use of 7.5% glucose polymer (mw 18700; mn 7300) + 0.35% glucose solution: a 3-month study. Nephrol Dial Transplant 1993; 8: 443–7.

    PubMed  CAS  Google Scholar 

  69. Ho-dac-Pannekeet MM, Schouten N, Langedijk MJ et al. Peritoneal transport characteristics with glucose polymer based dialysate. Kidney Int 1996; 50: 979–86.

    PubMed  CAS  Google Scholar 

  70. Wilkie ME, Plant MJ, Edwards L et al. Icodextrin 7.5% dialysate solution (glucose polymer) in patients with ultrafiltration failure: extension of CAPD technique survival. Perit Dial Int 1997; 17: 84–7.

    PubMed  CAS  Google Scholar 

  71. Davies DS. Kinetics of icodextrin. Perit Dial Int 1994; 14: (suppl. 2): S45–50.

    Google Scholar 

  72. Boeschoten EW, Krediet RT. Biocompatiblity of PD fluids. Nephrol Dial Transplant 1996; 11: 1907–11.

    Google Scholar 

  73. Lewis S, Holmes C. Host defense mechanisms in the peritoneal cavity of continuous ambulatory peritoneal dialysis patients. First of two parts. Petit Dial Int 1991; 11: 14–21.

    CAS  Google Scholar 

  74. Holmes C, Lewis S. Host defense mechanisms in the peritoneal cavity of continuous ambulatory peritoneal dialysis patients. Second of two parts. 2: Humoral defenses. Petit Dial Int 1991; 11: 112–17.

    CAS  Google Scholar 

  75. Vas SI. Peritonitis. In: Nolph KD, ed. Peritoneal Dialysis. Dordrecht: Kluwer, 1989, pp. 261–88.

    Google Scholar 

  76. Tranaeus A, Heimbürger O, Lindholm B. Peritonitis during continuous ambulatory peritoneal dialysis (CAPD): risk factors, clinical severity, and pathogenetic aspects. Perit Dial Int 1988; 8: 253–63.

    Google Scholar 

  77. Prowant B, Nolph K, Ryan L et al. Peritonitis in continuous ambulatory peritoneal dialysis. Analysis of an 8-years experience. Nephron 1986; 43: 105–9.

    PubMed  CAS  Google Scholar 

  78. Bernardini J, Holley JL, Johnston JR et al. Analysis of ten-year trends in infections in adults on continuous ambulatory peritoneal dialysis (CAPD). Clin Nephrol 1991; 36: 29–34.

    PubMed  CAS  Google Scholar 

  79. Churchill DN, Taylor DW, Vas SI et al. Canadian CAPD Clinical Trials Group. Peritonitis in continuous ambulatory peritoneal dialysis (CAPD): a multi-centre randomized clinical trial comparing the Y-connector disinfectant system to standard systems. Petit Dial Int 1989; 9: 159–63.

    Google Scholar 

  80. Port FK, Held PJ, Nolph KD et al. Risk of peritonitis and technique failure by CAPD connection technique: a national study. Kidney Int 1992; 42: 967–74.

    PubMed  CAS  Google Scholar 

  81. Bommardeaux A, Quimet D, Galarnean A et al. Peritonitis in continuous ambulatory peritoneal dialysis. Impact of a compulsory switch from a standard to a Y-connector system in a single North American center. Am J Kidney Dis 1992; 19: 364–70.

    Google Scholar 

  82. Sweinburg FB, Seligman AM, Fine J. Transmural migration of intestinal bacteria. N Engl J Med 1950; 242: 747–51.

    Google Scholar 

  83. Wu G, Khanna R, Vas S et al. Is extensive diverticulosis of the colon a contra-indication to CAPD? Perit Dial Bull 1983; 3: 180–3.

    Google Scholar 

  84. Tranaeus A, Heimbürger O, Grangvist S. Diverticular disease of the colon: a risk factor for peritonitis in continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 1990; 5: 141–7.

    PubMed  CAS  Google Scholar 

  85. Pepersack F, d’Haene M, Toussaint C et al. Campylobacter jejuni peritonitis complicating continuous ambulatory peritonitis. J Clin Microbiol 1988; 16: 739–41.

    Google Scholar 

  86. Singh MM, Bhargava AN, Jain KP. Tuberculous peritonitis. An evaluation of pathogenic mechanisms, diagnostic procedures and therapeutic measures. N Engl J Med 1969; 281: 1091–4.

    PubMed  CAS  Google Scholar 

  87. Williams P, Khanna R, Oreopoulos DG. Treatment of peritonitis in patients on CAPD: no longer a controversy. Dial Transplant 1981; 10: 272.

    Google Scholar 

  88. Millikin SP, Matzke GR, Keane WF. Antimicrobial treatment of peritonitis associated with continuous ambulatory peritoneal dialysis. Petit Dial Int 1991; 11: 252–60.

    CAS  Google Scholar 

  89. The ad hoc advisory committee on peritonitis management. Peritoneal dialysis-related peritonitis treatment recommendations 1993 update. Petit Dial Int 1993; 13: 14–28.

    Google Scholar 

  90. Frieden TR, Munsiff SS, Low DE et al. Emergence of vancomycin-resistant enterococci in New York City. Lancet 1993; 342: 76–9.

    PubMed  CAS  Google Scholar 

  91. Bonten MJM, Hayden MK, Nathan C et al. Epidemiology of colonisation of patients and environment with vancomycinresistant enterococci. Lancet 1996; 348: 1615–19.

    PubMed  CAS  Google Scholar 

  92. Troidle L, Kliger HS, Gorban-Brennan N et al. Nine episodes of CPD-associated peritonitis with vancomycin resistant enterococci. Kidney Int 1996; 50: 1368–72.

    PubMed  CAS  Google Scholar 

  93. Noble WC, Virani Z, Cree RG. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol Lett 1992; 72: 195–8.

    PubMed  CAS  Google Scholar 

  94. Hiramatsu K, Hanaki H, Ino T et al. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 1997; 40: 135–6.

    PubMed  CAS  Google Scholar 

  95. Centers for Disease Control and Prevention: Staphylococcus aureus with reduced susceptibility to vancomycin. United States, 1997. MMWR 1997; 46: 813.

    Google Scholar 

  96. Vandamme P, Vercauteren E, Lammens C et al. Survey of enterococcal susceptibility patterns in Belgium. J Clin Microbiol 1996; 34: 2572–6.

    PubMed  CAS  Google Scholar 

  97. Lameire N, Vogelaers D, Verschraegen G et al. Vancomycin resistant enterococci–a treat to the nephrologist on the horizon? Glycopeptide-resistant enterococci and the ICDC-recommendations for limited use of glycopeptides. Nephrol Dial Transplant 1996; 11: 2402–6.

    PubMed  CAS  Google Scholar 

  98. Keane WE, Alexander SR, Bailie GR et al. Peritoneal dialysis-related peritonitis treatment recommendations: 1996 update. Petit Dial Int 1996: 16: 557–73.

    CAS  Google Scholar 

  99. Anding K, Krumme B, Pelz K et al. Pharmacokinetics and bactericidal activity of a single daily dose of netilmicin in the treatment of CAPD-associated peritonitis. Int J Clin Pharmacol Ther 1996; 34: 465–9.

    PubMed  CAS  Google Scholar 

  100. van der Hulst RJ, Boeschoten EW, Nielsen FW et al. Ototoxicity monitoring with ultra-high frequency audiometry in peritoneal dialysis patients treated with vancomycin or gentamicin. Otorhinolaryngology 1991; 53: 19–23.

    CAS  Google Scholar 

  101. Vas SI. Microbiological aspects of chronic amubulatory peritoneal dialysis. Kidney Int 1983; 23: 83–92.

    PubMed  CAS  Google Scholar 

  102. Bunke M, Brier ME, Golper TA. Culture-negative CAPD peritonitis: the Network 9 Study. Adv Petit Dial 1994; 10: 174–8.

    CAS  Google Scholar 

  103. Lye WC, Wong PL, Leong SO et al. Isolation of organisms in CAPD peritonitis: a comparison of two techniques. Adv Petit Dial 1994; 10: 166–8.

    CAS  Google Scholar 

  104. Nubé MJ, Vet JA, van Geelen JA. Bacterial and clinical sequelae of the twinbag system in continuous ambulatory peritoneal dialysis. A single centre study. Neth J Med 1994; 44: 191–8.

    PubMed  Google Scholar 

  105. Gokal R, Ramos JM, Ward MK et al. `Eosinophilic’ peritonitis in continuous ambulatory peritoneal dialysis (CAPD). Clin Nephrol 1981; 15: 328–30.

    PubMed  CAS  Google Scholar 

  106. Fenton P. Laboratory diagnosis of peritonitis in patients undergoing continuous ambulatory peritoneal dialysis. J Clin Pathol 1982; 35: 1181–4.

    PubMed  CAS  Google Scholar 

  107. Report of a working party of the BSAC: Diagnosis and management of peritonitis in CAPD. Lancet 1987; 1: 845–8.

    Google Scholar 

  108. Von Graevenitz A, Amsterdam D. Microbiological aspects of peritonitis associated with CAPD. Clin Microbiol Rev 1992; 5: 26.

    Google Scholar 

  109. Gokal R, Jakubowski C, King J et al. Outcome in patients on continuous ambulatory peritoneal dialysis and hemodialysis: 4-years analysis of a prospective multicentre study. Lancet 1987; 2: 1105–9.

    PubMed  CAS  Google Scholar 

  110. Fenton SSA. Peritonitis-related death among CAPD patients. Petit Dial Bull 1983; 3: 9–11.

    Google Scholar 

  111. Digenis GE, Abraham G, Savin E et al. Peritonitis-related deaths in continuous ambulatory peritoneal dialysis (CAPD) patients. Petit Dial Int 1990; 10: 45–7.

    CAS  Google Scholar 

  112. Tzamaloukas AH, Obermiller CE, Gibel LJ et al. Peritonitis associated with intra-abdominal pathology in continuous ambulatory peritoneal dialysis patients. Petit Dial Int 1993; 13 (suppl. 2): S335–7.

    Google Scholar 

  113. Wakeen MJ, Zimmerman SW, Bidwell D. Viscus perforation in peritoneal dialysis patients: diagnosis and outcome. Petit Dial Int 1994; 14: 371–7.

    CAS  Google Scholar 

  114. Bazzato G, Candini S, Coli U et al. A new technique of continuous ambulatory peritoneal dialysis (CAPD): double-bag system for freedom of patients and significant reduction of peritonitis. Clin Nephrol 1980; 13: 251–4.

    PubMed  CAS  Google Scholar 

  115. Buoncristiani U, Cazzari M, Quintaliani G et al. Abatement of exogenous peritonitis risk using the Perugia CAPD system. Dial Transplant 1983; 12: 14.

    Google Scholar 

  116. Maiorca R, Cancarini GC, Brasa S et al. Y system with disinfectant in the prevention of peritonitis in CAPD. Contr Nephrol 1987; 57: 178–84.

    CAS  Google Scholar 

  117. Scalamogna A, De Vecchi A, Castelnovo C et al. Long-term incidence of peritonitis in CAPD patients treated by the Y set technique: experience in a single center. Nephron 1990; 55: 24.

    PubMed  CAS  Google Scholar 

  118. Zimmerman SW, O’Brien M, Wiedenhoeft FA, Johnson CA. Staphylococcus aureus peritoneal catheter-related infections: a cause of catheter loss and peritonitis. Petit Dail Int 1988; 8: 191–5.

    Google Scholar 

  119. Davies SJ, Ogg CS, Cameron JS et al. Staphylococcus aureus nasal carriage, exit-site infections and catheter loss in patients treated with continuous ambulatory peritoneal dialysis (CAPD). Petit Dial Int 1989; 9: 61–4.

    CAS  Google Scholar 

  120. Pierratos A. Peritoneal dialysis glossary. Petit Dial Bull 1984; 1: 2–3.

    Google Scholar 

  121. Holley JL, Bernardini JB, Piraino B. Risk factors for tunnel infections in continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1991; 18: 344–8.

    PubMed  CAS  Google Scholar 

  122. Twardowsky ZJ. Peritoneal catheter exit-site infections: prevention, diagnosis, treatment and future directions. Semin Dial 1992; 5: 305–15.

    Google Scholar 

  123. Twardowski ZJ (ed.) Peritoneal Catheter Exit-Site Morphology and Pathology. Petit Dial Int 1996; 16: (suppl.) 3.

    Google Scholar 

  124. Holley JL, Foulks CJ, Moss AH et al. Ultrasound as a tool in the diagnosis and management of exit-site infections in continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1989; 14: 211–16.

    PubMed  CAS  Google Scholar 

  125. Plum J, Atrik S, Busch T et al. Oral versus intraperitoneal application of clindamycin in tunnel infections. A prospective, ramdomized study in CAPD patients. Petit Dial Int 1997; 17: 486–92.

    CAS  Google Scholar 

  126. Piraino B, Bernandini J, Sorkin M. A five-year study of the microbiologic results of exit-site infections and peritonitis in continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1987; 10: 281–6.

    PubMed  CAS  Google Scholar 

  127. Luzar MA, Brown C, Balf D et al. Exit-site care and exit-site infection in CAPD: results of a randomized multicenter trial. Petit Dial Int 1990; 10: 25–9.

    CAS  Google Scholar 

  128. Burkhart JM. Significance, epidemiology and prevention of peritoneal dialysis catheter infections. Petit Dial Int 1996; 16 (suppl. 1): 5340–6.

    Google Scholar 

  129. Luzar MA. Exit-site infection in continuous ambulatory dialysis: a review. Petit Dial Int 1991; 11: 333–40.

    CAS  Google Scholar 

  130. Khanna R, Twardowski ZJ. Peritoneal catheter exit-site (editorial). Petit Dial Int 1988; 8: 119–23.

    Google Scholar 

  131. Copley JP. Prevention of peritoneal dialysis catheter-related complications. Am J Kidney Dis 1987; 10: 401–7.

    PubMed  CAS  Google Scholar 

  132. Holley JL, Piriano BM. Complications of peritoneal dialysis: diagnosis and management. Semin Dial 1990; 3: 245–8.

    Google Scholar 

  133. Wanten GJA, Koolen MI, van Liebergen FJHM et al. Outcome and complications in patients treated with continuous ambulatory peritoneal dialysis (CAPD) at a single centre during 11 years. Neth J Med 1996; 49: 4–12.

    PubMed  CAS  Google Scholar 

  134. Robinson RJ, Leapman SB, Wetherington GM et al. Survival considerations of continuous ambulatory peritoneal dialysis. Surgery 1984; 96: 723–9.

    Google Scholar 

  135. Twardowski ZJ, Khanna R. Peritoneal dialysis access and exit site care. In: Gokal R, Nolph KD, eds. Peritoneal Dialysis. Dordrecht: Kluwer, 1994, pp. 271–314.

    Google Scholar 

  136. Diaz-Buxo. Mechanical complications of chronic peritoneal dialysis catheters. Semin Dial 1991; 4: 106–11.

    Google Scholar 

  137. Bargman JM. Complications of peritoneal dialysis related to increased intra-abdominal pressure. Kidney Int 1993; 43: S75–80.

    Google Scholar 

  138. Litherland J, Cupton EW, Ackrill PA et al. Computed tomographic peritoneography: CT manifestations in the investigation of leaks and abnormal collections in patients on CAPD. Nephrol Dial Transplant 1994; 9: 1449–52.

    PubMed  CAS  Google Scholar 

  139. Hemmeloff Andersen ICE, Dangaard-Morch P. Catheterography in the diagnosis of catheter failure in peritoneal dialysis. Clin Nephrol 1981; 16: 142–5.

    Google Scholar 

  140. Twardowski ZJ, Khanna R, Nolph KD et al. Intra-abdominal pressure during natural activities in patients treated with continuous ambulatory peritoneal dialysis. Nephron 1986; 44: 129–34.

    PubMed  CAS  Google Scholar 

  141. Rocco MV, Stone WJ. Abdominal hernias in chronic peritoneal dialysis patients: a review. Petit Dial Bull 1985; 5: 171–4.

    Google Scholar 

  142. Boeschoten EW, Krediet RT, Roos CM et al. Leakage of dialysate across the diaphragm: an important complication of continuous ambulatory peritoneal dialysis. Neth J Med 1986; 26: 242–6.

    Google Scholar 

  143. Heimbürger O, Waniewski J, Werynski A et al. Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity. Kidney Int 1990; 38: 495–506.

    PubMed  Google Scholar 

  144. Twardowski ZJ, Nolph KD, Khanna R et al. Peritoneal equilibrium test. Petit Dial Bull 1987; 7: 138–47.

    Google Scholar 

  145. Davies SJ, Brown B, Bryan J et al. Clinical evaluation of the peritoneal equilibration test: a population based study. Nephrol Dial Transplant 1993; 8: 64–70.

    PubMed  CAS  Google Scholar 

  146. Krediet RT, Imholz ALT, Struijk DG et al. Ultrafiltration failure in continuous ambulatory peritoneal dialysis. Petit Dial Int 1992; 12 (suppl. 2): S59–66.

    Google Scholar 

  147. Krediet RT, Boeschoten EW, Zuiderhoudt FMJ et al. Peritoneal transport characteristics of water, low-molecular weight solutes and protein during long-term continuous ambulatory peritoneal dialysis. Petit Dial Bull 1986; 2: 61–5.

    Google Scholar 

  148. Virga G, Amici G, da Rin G et al. Comparison of fast peritoneal equilibration tests with 1.36% and 3.86% glucose solutions. Blood Purif 1994; 12: 113–20.

    PubMed  CAS  Google Scholar 

  149. Ho-dac-Pannekeet MM, Atasever B, Struijk DG et al. Analysis of ultrafiltration failure in peritoneal dialysis patients by means of standard peritoneal permeability analysis. Petit Dial Int 1997; 17: 144–50.

    CAS  Google Scholar 

  150. Struijk DG, Krediet RT, Koomen GCM et al. Functional characteristics of the peritoneal membrane in long-term continuous ambulatory peritoneal dialysis. Nephron 1991; 59: 213–20.

    PubMed  CAS  Google Scholar 

  151. Selgas R, Fernandez-Reyes M-J, Bosque E et al. Functional longevity of the human peritoneum: how long is continuous peritoneal dialysis possible? Results of a prospective median long-term study. Am J Kidney Dis 1994; 23: 64–73.

    PubMed  CAS  Google Scholar 

  152. Davies SJ, Bryan J, Philips L et al. Longitudinal changes in peritoneal kinetics: the effect of peritoneal dialysis and peritonitis. Nephrol Dial Transplant 1996; 11: 448–506.

    Google Scholar 

  153. Monquil MCJ, Imholz ALT, Struijk DG et al. Does impaired transcellular water transport contribute to net ultrafiltration failure during CAPD? Petit Dial Int 1995; 15: 42–8.

    CAS  Google Scholar 

  154. Krediet RT, Zuyderhoudt FMJ, Boeschoten EW et al. Alterations in peritoneal transport and water during peritonitis in continuous ambulatory peritoneal dialysis patients. Fur J Clin Invest 1987; 17: 43–52.

    CAS  Google Scholar 

  155. Panasikk E, Pietrzak B, Klos M et al. Characteristics of peritoneum after peritonitis in CAPD patients. Adv Petit Dial 1988; 4: 42.

    Google Scholar 

  156. Verger C, Cilicout B. Peritoneal permeability and encapsulating peritonitis. Lancet 1985; 1: 986–7.

    PubMed  CAS  Google Scholar 

  157. Krediet RT, Struijk DG, Boeschoten EW et al. The time course of peritoneal transport kinetics in continuous ambulatory peritoneal dialysis patients who develop sclerosing peritonitis. Am J Kidney Dis 1989; 13: 299–307.

    PubMed  CAS  Google Scholar 

  158. Krediet RT. The peritoneal membrane in chronic peritoneal dialysis. Nephrology forum. Kidney Int 1999; 55: 341–56.

    PubMed  CAS  Google Scholar 

  159. Dobbie JW. Pathogenesis of peritoneal fibrosing syndromes (sclerosing peritonitis) in peritoneal dialysis. Petit Dial Int 1992; 12: 14–27.

    CAS  Google Scholar 

  160. Marichal JF, Faller B, Brignon P. Progressive calcifying peritonitis: a new complication of CAPD? Nephron 1987; 45: 229–32.

    PubMed  CAS  Google Scholar 

  161. Korzets A, Korzets Z, Peer G et al. Sclerosing peritonitis: possible early diagnosis by computerized tomography of the abdomen. Am J Nephrol 1988; 8: 143–6.

    PubMed  CAS  Google Scholar 

  162. Hendriks PMEM, Ho-dac-Pannekeet MM, van Gulik TM et al. Peritoneal sclerosis in chronic peritoneal dialysis patients: analysis of clinical presentation, risk factors, and peritoneal transport kinetics. Petit Dial Int 1997; 17: 136–43.

    CAS  Google Scholar 

  163. Schmidt RW, Blumenkrantz M. Peritoneal sclerosis: a sword of Damocles for peritoneal dialysis? Arch Intern Med 1981; 141: 1265–7.

    PubMed  CAS  Google Scholar 

  164. Mutoh S, Machida J, Ueda S et al. Sclerosing encapsulating peritonitis occurring after very-short-term intermittent peritoneal dialysis. Nephron 1992; 62: 119–20.

    PubMed  CAS  Google Scholar 

  165. Palmer RA, Newell JE, Gray ES et al. Treatment of chronic renal failure by prolonged peritoneal dialysis. N Engl J Med 1966; 274: 248–54.

    PubMed  CAS  Google Scholar 

  166. Lindholm B, Bergström J. Nutritional reguirements of peritoneal dialysis patients. In: Gokal R, Nolph KD, eds. Textbook of Peritoneal Dialysis. Dordrecht: Kluwer, 1994, pp. 443–72.

    Google Scholar 

  167. Young GA, Kopple JD, Lindholm B et al. Nutritional assessment of continuous ambulatory dialysis patients: an international study. Am J Kidney Dis 1991; 17: 462–71.

    PubMed  CAS  Google Scholar 

  168. Harty JC, Boulton H, Curwell H et al. The normalized protein catabolic rate is a flawed marker of nutrition in CAPD patients. Kidney Int 1994; 43: 103–9.

    Google Scholar 

  169. Detsky AS, McLaughlin JR, Baker JP et al. What is subjective global assessment of nutritional status? J Parent Ent Nutt 1987; 11: 8–13.

    CAS  Google Scholar 

  170. Churchill DN, Taylor W, Keshaviah PR. Adequacy of dialysis and nutrition in continuous peritoneal dialysis. Association with clinical outcomes. J Am Soc Nephrol 1996; 7: 198–207.

    Google Scholar 

  171. NKF-DOQI clinical practice guidelines for peritoneal dialysis adequacy. Am J Kidney Dis 1997; 3 (suppl. 2): S67–133.

    Google Scholar 

  172. Blumenkrantz MJ, Kopple JD, Moran JK et al. Metabolic balance studies and dietary protein requirement in patients undergoing continuous ambulatory peritoneal dialysis. Kidney Int 1982; 21: 849–61.

    PubMed  CAS  Google Scholar 

  173. Blake PG, Sombolos K, Abraham G et al. Lack of correlation between urea kinetic indices and clinical outcomes in CAPD patients. Kidney Int 1991; 39: 700–6.

    PubMed  CAS  Google Scholar 

  174. Bergström J, Fürst P, Alvestrand A et al. Protein and energy intake, nitrogen balance and nitrogen losses in patients treated with continuous ambulatory peritoneal dialysis. Kidney Int 1993; 44: 1048–57.

    PubMed  Google Scholar 

  175. Jacob V, Marchant PR, Wild G et al. Nutritional profile of continuous ambulatory peritoneal dialysis patients. Nephron 1995; 71: 16–22.

    PubMed  CAS  Google Scholar 

  176. Jones M, Hagen T, Algrim Boyle C et al. Treatment of malnutrition with 1.1% amino acid peritoneal dialysis solution: results of a multicenter outpatient study. Am J Kidney Dis 1998; 32: 761–9.

    PubMed  CAS  Google Scholar 

  177. Bayer H von, Gahl GM, Riedinger H et al. Adaptation of CAPD patients to the continuous peritoneal energy uptake. Kidney Int 1983; 23: 29–34.

    Google Scholar 

  178. Boeschoten EW, Zuyderhoudt FMJ, Krediet RT et al. Changes in weight and lipid concentrations during CAPD treatment. Petit Dial Int 1988; 8: 19–25.

    Google Scholar 

  179. Faller B, Lameire N. Evolution of clinical parameters and peritoneal function in a cohort of CAPD patients followed over 7 years. Nephrol Dial Transplant 1994; 9: 280–6.

    PubMed  CAS  Google Scholar 

  180. Heaton A, Johnston DG, Burrin JM et al. Carbohydrate and lipid metabolism during continuous ambulatory peritoneal dialysis: the effect of a single dialysis cycle. Clin Sci 1983; 65: 539–45.

    PubMed  CAS  Google Scholar 

  181. Amstrong VW, Creutzfeldt W, Ebert R et al. Effect of dialysis glucose load on plasma and glucoregulatory hormones in CAPD patients. Nephron 1985; 39: 141–5.

    Google Scholar 

  182. Wideroe TE, Smeby LC, Myking OL. Plasma concentrations and transperitoneal transport of native insulin and C-peptide in patients on continuous ambulatory peritoneal dialysis. Kidney Int 1984; 25: 82–7.

    PubMed  CAS  Google Scholar 

  183. Lameire N, Matthys E, Boheydt R. Effects of long-term CAPD on carbohydrate and lipid metabolism. Clin Nephrol 1988; 30: S53–8.

    PubMed  Google Scholar 

  184. Llopart R, Donate T, Oliva JA et al. Triglyceride-rich lipoprotein abnormalities in CAPD-treated patients. Nephrol Dial Transplant 1995; 10: 537–40.

    PubMed  CAS  Google Scholar 

  185. O’Neal D, Lee P, Murphy B et al. Low-density lipoprotein particle size distribution in end-stage renal disease treated with hemodialysis or peritoneal dialysis. Am J Kidney Dis 1996; 27: 84–91.

    PubMed  Google Scholar 

  186. Austin MA, Breslow JL, Hennekens CH et al. Low density lipoprotein subclass pattern and the risk of myocardial infarction. JAMA 1988; 260: 1917–21.

    PubMed  CAS  Google Scholar 

  187. Saku K, Sasaki J, Naito S et al. Lipoprotein and apolipoprotein losses during continuous ambulatory peritoneal dialysis. Nephron 1989; 51: 220–4.

    PubMed  CAS  Google Scholar 

  188. Shoji T, Nishizawa Y, Nishitani H et al. Roles of hypoalbuminemia and lipoprotein lipase on hyperlipoproteinemia in continuous ambulatory peritoneal dialysis. Metabolism 1991; 10: 1002–8.

    Google Scholar 

  189. Levey AS, Beto JA, Coronado BE et al. Controlling the epidemic of cardiovascular disease in chronic renal disease. What do we need now? What do we need to learn? Where do we go from here? Am J Kidney Dis 1998; 32: 853–906.

    PubMed  CAS  Google Scholar 

  190. Blumenkrantz MJ, Gahl GM, Kopple JD et al. Protein losses during peritoneal dialysis. Kidney Int 1981; 19: 593–602.

    PubMed  CAS  Google Scholar 

  191. Krediet RT, Imholz ACT, Zemel D et al. Clinical significance and detention of individual differences and changes in trans-peritoneal transport. Blood Purif 1994; 12: 211–32.

    Google Scholar 

  192. Boeschoten EW, Schrijver J, Krediet RT et al. Deficiencies of vitamins in CAPD patients. The effect of supplementation. Nephrol Dial Transplant 1988; 2: 187–93.

    Google Scholar 

  193. Brown-Cartwright D, Smith HJ, Feldman M. Gastric emptying of an indigestible solid in patients with end-stage renal disease on continuous ambulatory peritoneal dialysis. Gastroenterology 1988; 95: 49–51.

    PubMed  CAS  Google Scholar 

  194. Bird NJ, Streather CP, O’Doharty MJ et al. Gastric emptying in patients with chronic renal failure on continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 1993; 9: 287–90.

    Google Scholar 

  195. Gallar P, Oliet A, Vigil A et al. Gastroparesis: an important cause of hospitalization in continuous ambulatory peritoneal dialysis patients and the role of erythromycin. Petit Dial Int 1993; 13: (suppl. 2): S183–86.

    Google Scholar 

  196. Korzets Z, Golan E, Ben-Dahan J et al. Decubitus small-bowel perforation in ongoing continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 1992; 7: 79–81.

    PubMed  CAS  Google Scholar 

  197. Nelson W, Khanna R, Mathews R et al. Gallbladder stones, cholecystitis and cholecystectomy in patients on continuous ambulatory peritoneal dialysis. Petit Dial Bull 1984; 4: 245–8.

    Google Scholar 

  198. Bargman JM. The impact of intraperitoneal glucose and insulin on the liver. Perit Dial Int 1996; 16 (suppl.1): S211–14.

    PubMed  Google Scholar 

  199. Luciani L, Gentile M, Scarduelli B et al. Multiple hepatic abscesses complicating continuous ambulatory peritoneal dialysis. Br Med J 1982; 285: 543.

    CAS  Google Scholar 

  200. Goodman W, Gallagher N, Sherrard DJ. Peritoneal dialysis fluid as a source of hepatitis antigen. Nephron 1981; 29: 107–9.

    PubMed  CAS  Google Scholar 

  201. Gupta A, Yuan ZY, Balaskas EV et al. CAPD and pancreatitis: no connection. Petit Dial Int 1992; 12: 309–16.

    CAS  Google Scholar 

  202. Pannekeet MM, Krediet RT, Boeschoten EW et al. Acute pancreatitis during CAPD in the Netherlands. Nephrol Dial Transplant 1993; 8: 1376–81.

    PubMed  CAS  Google Scholar 

  203. Donnelly S, Levy M, Prichard S. Acute pancreatitis in continuous ambulatory peritoneal dialysis (CAPD). Petit Dial Int 1988; 8: 187–90.

    Google Scholar 

  204. Movilli E, Natale C, Cancarini GC et al. Improvement of iron utilization and anemia in uremic patients switched from hemodialysis to continuous ambulatory peritoneal dialysis. Petit Dial Bull 1986; 6: 147–9.

    Google Scholar 

  205. Salahudeen AK, Keavey PM, Hawkins T et al. Is anemia during CAPD really better than during hemodialysis? Lancet 1983; 2: 1046–9.

    PubMed  CAS  Google Scholar 

  206. Kurtz SB, Wong VH, Anderson CF et al. Continuous ambulatory peritoneal dialysis. Three years’ experience at the Mayo Clinic. Mayo Clin Proc 1983; 58: 633–9.

    PubMed  CAS  Google Scholar 

  207. De Paepe MB, Schelstraete KGH, Ringoir SM et al. Influence of continuous ambulatory peritoneal dialysis on the anemia of end stage renal disease. Kidney Int 1983; 23: 744–8.

    PubMed  Google Scholar 

  208. Saltissi D, Coles GA, Napier JAF et al. The hematological response to continuous ambulatory peritoneal dialysis. Clin Nephrol 1984; 22: 21–7.

    PubMed  CAS  Google Scholar 

  209. Lameire N. Matthys E, de Paepe M, et al. Red-cell survival in patients on continuous ambulatory peritoneal dialysis. Petit Dial Bull 1986; 6: 65–8.

    Google Scholar 

  210. Lamperi S, Carozzi S, Icardi A. In vitro and in vivo studies of erythropoiesis during continuous ambulatory peritoneal dialysis. Petit Dial Bull 1983; 3: 94–6.

    Google Scholar 

  211. Nakagawa S. An introductory approach to recently invested metabolic and endocrinological problems in uremia. Nephrol Dial Transplant 1989; 4 (suppl.): 123–6.

    Google Scholar 

  212. Rottembourg J. Residual renal function and recovery of renal functions in patients treated by CAPD. Kidney Int 1993; 43 (suppl. 40): 5106–10.

    Google Scholar 

  213. Eschbach JW, Egrie JC, Downing MR et al. Correction of the anaemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial. N Engl J Med 1987; 316: 73–8.

    PubMed  CAS  Google Scholar 

  214. Boelaert JR, Schurgers MC, Matthys EG et al. Comparative pharmacokinetics of recombinant erythropoietin administered by the intravenous, subcutaneous and intraperitoneal routes in continuous ambulatory peritoneal dialysis (CAPD) patients. Petit Dial Int 1989; 9: 95–8.

    CAS  Google Scholar 

  215. Piraino B, Johnston JR. The use of subcutaneous erythropoietin in CAPD. Clin Nephrol 1990; 33: 200–2.

    PubMed  CAS  Google Scholar 

  216. Stevens JM, Auer J, Strong CA et al. Stepwise correction of anaemia by subcutaneous administration of human recombinant erythropoietin in patients with chronic renal failure maintained by continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 1991; 6: 487–94.

    PubMed  CAS  Google Scholar 

  217. Hörl WH, Cavill I, Macdougall IC et al. How to diagnose and correct iron deficiency during r-hu EPO therapy–a consensus report. Nephrol Dial Transplant 1996; 11: 246–50.

    PubMed  Google Scholar 

  218. Lameire N, Bernaert P, Lambert M-C et al. Cardiovascular risk factors and their management in patients on continuous ambulatory peritoneal dialysis. Kidney Int 1994; 46 (suppl. 48): S31–8.

    Google Scholar 

  219. Luke RG. Chronic renal failure–a vasculopathic state. N Engl J Med 1998; 339: 841–3.

    PubMed  CAS  Google Scholar 

  220. Maiorca R, Cancarini GC, Lamerini C et al. Is CAPD competitive with hemodialysis for long-term treatment of uremic patients? Nephrol Dial Transplant 1989; 4: 244–53.

    PubMed  CAS  Google Scholar 

  221. Leenen F, Smith D, Khanna R et al. Changes in left ventricular anatomy and function on CAPD. Petit Dial Bull 1983; 3 (suppl.): S26–8.

    Google Scholar 

  222. Eisenberg M, Prichard S, Barre P et al. Left ventricular hypertrophy in end-stage renal disease on peritoneal dialysis. Am J Cardiol 1987; 60: 418–19.

    PubMed  CAS  Google Scholar 

  223. Huting J, Schutterle G. Cardiovascular factors influencing survival in end-stage renal disease treated by continuous ambulatory peritoneal dialysis. Am J Cardiol 1992; 69: 123–7.

    PubMed  CAS  Google Scholar 

  224. Held PJ, Port FK, Webb RL. Excerpts from United States Renal Data System 1991; Annual Data Report. Am J Kidney Dis 1991; 18 (suppl. 2): 1–127.

    PubMed  CAS  Google Scholar 

  225. Stablein DM, Hamburger RJ, Lindblad AS et al. The effect of CAPD on hypertension control: a report of the National CAPD Registry. Petit Dial Int 1988; 8: 141–4.

    Google Scholar 

  226. Davies SJ, Phillips L, Russell GI. Peritoneal solute transport predicts survival on CAPD independently of residual renal function. Nephrol Dial Transplant 1998; 13: 962–8.

    PubMed  CAS  Google Scholar 

  227. Wang T, Heimbürger O, Waniewski J et al. Increased peritoneal permeability is associated with decreased fluid and small-solute removal and higher mortality in CAPD patients. Nephrol Dial Transplant 1998; 13: 1242–9.

    PubMed  CAS  Google Scholar 

  228. Coles GA. Have we underestimated the importance of fluid balance for the survival of PD patients? Petit Dial Int 1997; 17: 321–7.

    CAS  Google Scholar 

  229. Bergström J, Lindholm B. Malnutrition, cardial disease and mortality: an integrated point of view. Am J Kidney Dis 1998; 32: 834–41.

    PubMed  Google Scholar 

  230. Besselink RA, Schröder CH, van Oort AM. Influence of dialysate exchange on cardial left ventricular function in children treated with CAPD. Petit Dial Int 1991; 11: 141–3.

    CAS  Google Scholar 

  231. Brown P, Johnston K, Fenton S et al. Symptomatic exacerbation of peripheral vascular disease with chronic ambulatory peritoneal dialysis. Clin Nephrol 1981; 16: 258–61.

    PubMed  CAS  Google Scholar 

  232. Llach F, Boyer J. Renal osteodystrophy. In: Brenner BM, ed. The Kidney. Philadelphia, PA: WB Saunders, 1996, pp. 2187–273.

    Google Scholar 

  233. Malluche HH, Faugere MC. Renal bone disease 1990: an unmet challenge for the nephrologist. Kidney Int 1990; 38: 193–211.

    PubMed  CAS  Google Scholar 

  234. Pei Y, Hercz G, Greenwood C et al. Non-invasive prediction of aluminium bone disease in hemo and peritoneal dialysis patients. Kidney Int 1992; 41: 1374–82.

    PubMed  CAS  Google Scholar 

  235. Sherrard DJ, Hercz G, Pei Y et al. The spectrum of bone disease in end-stage renal failure. An evolving disorder. Kidney Int 1993; 43: 436–42.

    Google Scholar 

  236. Martis L, Serkes K, Nolph KD. Calcium carbonate as a phosphate binder: is there a need to adjust peritoneal dialysate calcium concentrations for patients using calcium carbonate? Petit Dial Int 1989; 9: 325–8.

    CAS  Google Scholar 

  237. Digenis G, Khanna R, Pierratos A et al. Renal osteodystrophy in patients managed on CAPD for more than three years. Petit Dial Bull 1983; 3: 81–6.

    Google Scholar 

  238. Cunningham J, Beer J, Coldwell RD et al. Dialysate calcium reduction in CAPD patients treated with calcium carbonate and alfacalcidol. Nephrol Dial Transplant 1992; 7: 63–8.

    PubMed  CAS  Google Scholar 

  239. Hutchison AJ, Gokal R. Towards tailored dialysis fluids in CAPD/the role of reduced calcium and magnesium in dialysis. Petit Dial Int 1992; 12: 199–203.

    CAS  Google Scholar 

  240. Weinreich T, Passlick-Deetjen, Ritz E. Low dialysate calcium in continuous ambulatory peritoneal dialysis. A randomized controlled multicenter trial. Am J Kidney Dis 1995; 25: 452–60.

    CAS  Google Scholar 

  241. Buijsen C, Struijk DG, Huijgen H et al. The PTH-ionized calcium (i Ca) relationship in CAPD patients (pt) during low calcium solution. Petit Dial Int 1994; 14: S33 (abstract).

    Google Scholar 

  242. Warren DJ, Otieno LS. Carpal tunnel syndrome in patients on intermittent hemodialysis. Postgrad Med J 1975; 51: 450–2.

    PubMed  CAS  Google Scholar 

  243. Gagnon RF, Somerville P, Kaye M. 32-Microglobulin levels in patients on long-term dialysis. Petit Dial Bull 1987; 7: 29–31.

    Google Scholar 

  244. Blumberg A, Bürgi W. Behavior of ß2 microglobulin in patients with chronic renal failure undergoing haemodialysis, haemofiltration and continuous peritoneal dialysis (CAPD). Clin Nephrol 1987; 27: 245–9.

    PubMed  CAS  Google Scholar 

  245. Tieleman C. Dratwa M, Bergmann P et al. Continuous ambulatory peritoneal dialysis vs hemodialysis: a lesser risk of amyloidosis. Nephrol Dial Transplant 1988; 3: 291–4.

    PubMed  Google Scholar 

  246. Cornelis F, Bardin T, Faller B et al. Rheumatic syndromes and (32-M amyloidosis in patients receiving long-term peritoneal dialysis. Arthritis Rheum 1989; 32: 785–8.

    PubMed  CAS  Google Scholar 

  247. Benz RL, Siegfried JW, Teehan BP. Carpal tunnel syndrome in dialysis patients; comparison between continuous ambulatory peritoneal dialysis and hemodialysis population. Am J Kidney Dis 1988; 11: 473–6.

    PubMed  CAS  Google Scholar 

  248. Deppner TA. Prescribing Hemodialysis: a guide to urea modelling. Dordrecht: Kluwer, 1991, pp. 25–38.

    Google Scholar 

  249. Lowrie EG, Laird NM, Parker TF, Sargent JA. Effect of the hemodialysis prescription on patient morbidity. N Engl J Med 1981; 305: 1176–81.

    PubMed  CAS  Google Scholar 

  250. Deppner TA. Quantifying hemodialysis and peritoneal dialysis: examination of the peak concentration hypothesis. Semin Dial 1994; 7: 315–17.

    Google Scholar 

  251. Lindsay RM, Spanner E. A hypothesis: the protein catabolic rate is dependent upon the type and amount of treatment in dialyzed uremic patients. Am J Kidney Dis 1989; 13: 382–9.

    PubMed  CAS  Google Scholar 

  252. Harty JC, Farragher B, Boulton H et al. Is the correlation between the normalized catabolic rate and Kt/V the result of mathematical coupling? J Am Soc Nephrol 1993; 4: 407.

    Google Scholar 

  253. Randerson DH, Chapman GV, Farrell PC. Animo acid and dietary status in long-term CAPD patients. In: Atkins RC, Farrel PC, Thomson N, eds. Peritoneal Dialysis. Edinburgh: Churchill Livingstone, 1981, pp. 179–91.

    Google Scholar 

  254. Teehan BP, Schleifer CR, Sigler MH et al. A quantitative approach to the CAPD prescription. Petit Dial Bull 1985; 5: 152–6.

    Google Scholar 

  255. NKF-DOQI Committee. Appendix E: a detailed rationale for guideline 9. Am J Kidney Dis 1997; 30 (suppl. 2): S122–5.

    Google Scholar 

  256. Blumenkrantz MJ, Kopple JD, Moran JK et al. Nitrogen and urea metabolism during continuous ambulatory peritoneal dialysis. Kidney Int 1981; 20: 78–82.

    PubMed  CAS  Google Scholar 

  257. Nolph KD, Moore HL, Prowant B et al. Cross sectional assessment of weekly urea and creatinine clearances and indices of nutrition in continuous ambulatory peritoneal dialysis patients. Petit Dial Int 1993; 13: 178–83.

    CAS  Google Scholar 

  258. Maiorca R, Brunori G, Zubani R et al. Predictive value of dialysis adequacy and nutritional indices for mortality and morbidity in CAPD and HD patients. A longitudinal study. Nephrol Dial Transplant 1995; 10: 2295–305.

    PubMed  CAS  Google Scholar 

  259. Churchill DN, Taylor W, Keshaviah PR. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. J Am Soc Nephrol 1996; 7: 198–207.

    Google Scholar 

  260. NKF-DOQI Committee. Clinical outcomes goals for adequate peritoneal dialysis. Am J Kidney Dis 1997; 30 (suppl. 2): 595–100.

    Google Scholar 

  261. Blake PG, Sombolos K, Abraham G et al. Lack of correlation between urea kinetic indices and clinical outcomes in CAPD-patients. Kidney Int 1991; 39: 700–6.

    PubMed  CAS  Google Scholar 

  262. Teehan BP, Schleifer CR, Brown J. Urea kinetic modeling in an appropriate assessment of adequacy. Semin Dial 1992; 5: 189.

    Google Scholar 

  263. Brandes JC, Piering WF, Beres JA et al. Clinical outcome of continuous ambulatory peritoneal dialysis predicted by urea and creatinine kinetics. J Am Soc Nephrol 1992; 2: 140–3.

    Google Scholar 

  264. NKF-DOQI Committee. Adequate dose of peritoneal dialysis. Am J Kidney Dis 1997; 30 (suppl. 2): S86–92.

    Google Scholar 

  265. Churchill DN, Thorpe KE, Nolph KD et al. CAPD patient and technique survivals are worse with increased membrane permeability. Petit Dial Int 1996; 16 (suppl. 2): S21.

    Google Scholar 

  266. Tattersall JE, Doyle S, Greenwood RN et al. Maintaining adequacy in CAPD by individualizing the dialysis prescription. Nephrol Dial Transplant 1994; 9: 749–52.

    PubMed  CAS  Google Scholar 

  267. Manis T, Friedman EA. Dialytic therapy for irreversible uremia. N Engl J Med 1979; 301: 1321–8.

    PubMed  CAS  Google Scholar 

  268. Mignon F, Michel C, Viron B et al. Why so much disparity of PD in Europe? Nephrol Dial Transplant 1998; 13: 1114–17.

    PubMed  CAS  Google Scholar 

  269. Jacobs C, Broyer M, Brunner FP et al. Combined report on regular dialysis and transplantation in Europe. Proc EDTA 1981; 18: 2–58.

    Google Scholar 

  270. Kramer P, Brayer M, Brunner FP et al. Combined report on regular dialysis and transplantation in Europe. Proc EDTA 1982; 19: 4–59.

    Google Scholar 

  271. Ramos JM, Gokal R, Siamopolous K et al. Continuous ambulatory peritoneal dialysis: three years’ experience. Quart J Med 1983; 206: 165–86.

    Google Scholar 

  272. Clarytan C, Spinowitz BS, Galler M. A comparative study of continuous ambulatory peritoneal dialysis and center hemodialysis. Efficacy, complications and outcome in the treatment of end-stage renal disease. Arch Intern Med 1986; 146: 1138–43.

    Google Scholar 

  273. Burton PR, Walls J. Selection-adjusted comparison of life-expectancy of patients on continuous ambulatory peritoneal dialysis, hemodialysis and renal transplantation. Lancet 1987; 1: 1115–18.

    PubMed  CAS  Google Scholar 

  274. Maiorca R, Vonesh E, Cancarini GC et al. A six-year comparison of patient and technique survivals in CAPD and HD. Kidney Int 1988; 34: 518–24.

    PubMed  CAS  Google Scholar 

  275. Serkes KD, Blagg CR, Nolph KD et al. Comparison of patient and technique survival in continuous ambulatory peritoneal dialysis (CAPD) and hemodialysis: a multicenter study. Petit Dial Int 1990; 10: 15–19.

    CAS  Google Scholar 

  276. Wolfe RA, Port FK, Hawthrone VM et al. A comparison of survival among dialytic therapies of choice: in-center hemodialysis versus continuous ambulatory peritoneal dialysis at home. Am J Kidney Dis 1990; 15: 433–40.

    PubMed  CAS  Google Scholar 

  277. Gentil MA, Carriazo A, Paron MI et al. Comparison of survival in continuous ambulatory peritoneal dialysis and hospital hemodialysis: a multicentric study. Nephrol Dial Transplant 1991; 6: 444–51.

    PubMed  CAS  Google Scholar 

  278. Held PJ, Port FK, Turenne MN et al. Continuous ambulatory peritoneal dialysis and hemodialysis: comparison of patient mortality with adjustment for comorbid conditions. Kidney Int 1994; 45: 1163–9.

    PubMed  CAS  Google Scholar 

  279. Bloembergen WE, Port FK, Mauger EA et al. A comparison of mortality between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol 1995; 6: 177–83.

    PubMed  CAS  Google Scholar 

  280. Fenton SSA, Schaubel DE, Desmeules M et al. Hemodialysis versus peritoneal dialysis: a comparison of adjusted mortality rates. Am J Kidney Dis 1997; 30: 334–42.

    PubMed  CAS  Google Scholar 

  281. Maiorca R, Vonesh EF, Cavalli PL et al. A multicenter selection-adjusted comparison of patient and technique survivals on CAPD and hemodialysis. Petit Dial Int 1991; 11: 118–27.

    CAS  Google Scholar 

  282. Wilson PG. Psychiatric aspects of the dialysis patient. In: Jacobs C, Kjellstrand CM, Koch KM, Winchester JF, eds. Replacement of Renal Function by Dialysis. Dordrecht: Kluwer, 1996, pp. 1455–65.

    Google Scholar 

  283. Reiss D. Patient, family, and staff responses to end-stage renal disease. Am J Kidney Dis 1990; 15: 194–200.

    Google Scholar 

  284. O’Brien ME. Compliance behaviour and long-term maintenance dialysis. Am J Kidney Dis 1990; 15: 209–14.

    PubMed  Google Scholar 

  285. Sharpe M, Mayou R, Seagroatt V et al. Why do doctors find some patients difficult to help? Q J Med 1994; 87: 187–93.

    PubMed  CAS  Google Scholar 

  286. Morduchowicz G, Sylkes J, Aizic S et al. Compliance in hemodialysis patients: a multivariate regression analysis. Nephron 1993; 64: 365–8.

    PubMed  CAS  Google Scholar 

  287. Kobrin SM, Kimmel PL, Simmens SJ et al. Behavioral and biochemical indices of compliance in hemodialysis patients. ASAIO Trans 1991; 37: M378–80.

    PubMed  CAS  Google Scholar 

  288. Blake PG. Do mortality rates differ between hemodialysis and CAPD? A look at the Canadian vs U.S. data. Dial Transplant 1996; 25: 75.

    Google Scholar 

  289. Ahlmén J. Quality of life in the dialysis patient. In: Jacobs C, Kjellstrand CM, Koch KM, Winchester JF, eds. Replacement of Renal Function by Dialysis. Dordrecht: Kluwer, 1996, pp. 1466–79.

    Google Scholar 

  290. Robine J-M. Measuring the burden of disease. Lancet 1998; 352: 757–8.

    PubMed  CAS  Google Scholar 

  291. Weinstein MC, Stason WB. Foundations of cost effective analysis for health and medical practices. N Engl J Med 1977; 296: 716–21.

    PubMed  CAS  Google Scholar 

  292. Simmons RG, Abress L. Quality of life issues for end-stage renal disease patients. Am J Kidney Dis 1990; 15: 201–8.

    PubMed  CAS  Google Scholar 

  293. Evans RW, Manninen DL, Garrison LP et al. The quality of life of patients with end-stage renal failure. N Engl J Med 1985; 312: 553–9.

    PubMed  CAS  Google Scholar 

  294. Morris P, Jones B. Transplantation versus dialysis: a study of quality of life. Transplant Proc 1988; 20: 23–6.

    PubMed  CAS  Google Scholar 

  295. Petrie K. Psychological well-being and psychiatric disturbance in dialysis and renal transplant patients. Br J Med Psycho] 1989; 62: 91–6.

    Google Scholar 

  296. Simmons RG, Anderson BA, Kamstra L. Comparison of quality of life of patients on continuous ambulatory peritoneal dialysis, hemodialysis, and after transplantation. Am J Kidney Dis 1984; 4: 253–5.

    PubMed  CAS  Google Scholar 

  297. Churchill DN, Torrance GW, Taylor W et al. Measurement of quality of life in end-stage renal disease: the time trade-off approach. Clin Invest Med 1987; 10: 14–20.

    PubMed  CAS  Google Scholar 

  298. Wolcott DL, Nistenson AR. Quality of life in chronic dialysis patients: a clinical comparison of continuous ambulatory peritoneal dialysis (CAPD) and hemodialysis. Am J Kidney Dis 1988; 11: 402–12.

    PubMed  CAS  Google Scholar 

  299. Bremer BA, McCauley CR, Wrona RM et al. Quality of life in end-stage renal disease: a reexamination. Am J Kidney Dis 1989; 13: 200–9.

    PubMed  CAS  Google Scholar 

  300. Tucker CM, Ziller RL, Smith WR et al. Quality of life of patients on in-centre hemodialysis versus continuous ambulatory peritoneal dialysis. Petit Dial Int 1991; 11: 341–6.

    CAS  Google Scholar 

  301. Gokal R. Quality of life in patients undergoing renal replacement therapy. Kidney Int 1993; 40 (suppl.): 523–7.

    Google Scholar 

  302. Griffin KW, Wadhwa NK, Friend R et al. Comparison of quality of life in hemodialysis and peritoneal dialysis. Adv Petit Dial 1994; 10: 104–8.

    CAS  Google Scholar 

  303. Canadian Erythropoietin Study Group. Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving hemodialysis. Br Med J 1990; 300: 573–8.

    Google Scholar 

  304. Auer J, Simon G, Oliver DO et al. Improvements in quality of life of CAPD patients treated with subcutaneously administered erythropoietin for anemia. Petit Dial Int 1992; 12: 40–2.

    CAS  Google Scholar 

  305. Merkus MP, Jager KJ, Dekker FW et al. Quality of life in patients on chronic dialysis: self-assessment 3 months after the start of treatment. Am J Kidney Dis 1997; 29: 584–92.

    PubMed  CAS  Google Scholar 

  306. Garrat AM, Ruta DA, Abdalla MI et al. The SF-36 health survey questionnaire: an outcome measure suitable for routine use within the NHS? Br Med J 1993; 306: 1437–40.

    Google Scholar 

  307. de Wit A, Ramsteijn PG, de Charro FTh. Economic evaluation of end-stage renal disease treatment. Health Policy 1998; 44: 215–32.

    PubMed  CAS  Google Scholar 

  308. Campbell J, Ewigman B, Hosokawa M et al. The timing of referral of patients with end stage renal disease. Dial Transplant 1989; 18: 660.

    Google Scholar 

  309. Stephenson K, Villano R. Results of a predialysis education program. Dial Transplant 1993; 22: 566.

    Google Scholar 

  310. Hood SA, Sandheimer JH. Impact of pre-ESRD management on dialysis outcomes: a review. Semin Dial 1998; 11: 175–80.

    Google Scholar 

  311. Kilner JF. Ethical issues in the initiation and termination of treatment. Am J Kidney Dis 1990; 15: 218–27.

    PubMed  CAS  Google Scholar 

  312. Port FK. Mortality and causes of death in patients with end-stage renal failure. Am J Kidney Dis 1990; 15: 215–17.

    PubMed  CAS  Google Scholar 

  313. Finkelstein FO, Sorkin M, Cramton CW et al. Initiatives on peritoneal dialysis: where do we go from here? Petit Dial Int 1991; 11: 274–8.

    CAS  Google Scholar 

  314. Posthuma N, Borgstein PJ, Eijsbouts Q et al. Simultaneous peritoneal dialysis catheter insertion and removal in catheter-related infections without interruption of peritoneal dialysis. Nephrol Dial Transplant 1998; 13: 700–3.

    PubMed  CAS  Google Scholar 

  315. O’Donoghe D, Manos J, Pearson R et al. Continuous ambulatory peritoneal dialysis and renal transplantation: a ten-year experience in a single center. Petit Dial Int 1992; 12: 242–9.

    Google Scholar 

  316. Bakir N, Surachno S, Sluiter WJ et al. Peritonitis in peritoneal dialysis patients after renal transplantation. Nephrol Dial Transplant 1998; 13: 3178–83.

    PubMed  CAS  Google Scholar 

  317. Kurtz SB, Wong VH, Andersson CF et al. Continuous ambulatory peritoneal dialysis. Three years’ experience at the Mayo Clinic. Mayo Clin Proc 1983; 58: 633–9.

    PubMed  CAS  Google Scholar 

  318. Nolph KD, Cutler SJ, Steinberg SM et al. Continuous ambulatory peritoneal dialysis in the United States: a three year study. Kidney Int 1985; 28: 198–205.

    PubMed  CAS  Google Scholar 

  319. Gokal R, Baillod R, Boyle S et al. Multi-centre study on outcome of treatment in patients on continuous ambulatory peritoneal dialysis and hemodialysis. Nephrol Dial Transplant 1987; 2: 172–8.

    PubMed  CAS  Google Scholar 

  320. NKF-DOQI Committee. Initiation of dialysis. Am J Kidney Dis 1997; 30 (suppl. 2): S70–3.

    Google Scholar 

  321. Churchill DN. Adequacy of peritoneal dialysis: research needs. Semin Dial 1998; 11: 205–6.

    Google Scholar 

  322. Bonomini V. Early dialysis. Nephron 1979; 24: 157–60.

    PubMed  CAS  Google Scholar 

  323. Ratcliffe PJ, Phillips RE, Oliver DO. Late referral for maintenance dialysis. Br Med J 1984; 288: 441–3.

    CAS  Google Scholar 

  324. Jungers P, Zingraff J, Page B et al. Detrimental effects of late referral in patients with chronic renal failure: a case-control study. Kidney Int 1993 (suppl. 41 ): S170–3.

    Google Scholar 

  325. Hakim RM, Lazarus JM. Initiation of dialysis. J Am Soc Nephrol 1995; 6: 1319–28.

    PubMed  CAS  Google Scholar 

  326. Sesso R, Belasco AG. Late diagnosis of chronic renal failure and mortality on maintenance dialysis. Nephrol Dial Transplant 1996; 11: 2417–20.

    PubMed  CAS  Google Scholar 

  327. Infudu O, Dawood M, Homel P et al. Excess morbidity in patients starting uremia therapy without prior care by a nephrologist. Am J Kidney Dis 1996; 28: 841–5.

    Google Scholar 

  328. Methrotra R, Nolph KD. `Healthy’ initiation of chronic dialysis. Current research needs. Semin Dial 1998; 11: 213–15.

    Google Scholar 

  329. Struijk DG, Douma CE. Future research in peritoneal dialysis fluids. Semin Dial 1998; 11: 207–12.

    Google Scholar 

  330. Hoff CM, Shockley TR. Genetic modification of the peritoneal membrane: potential for improving peritoneal dialysis through gene therapy. Semin Dial 1998; 11: 218–27.

    Google Scholar 

  331. Golper TA. Research directions in peritonitis. Semin Dial 1998; 11: 216–17.

    Google Scholar 

Download references

Authors
  1. E. W. Boeschoten
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Renal Medicine, Manchester Royal Infirmary, Oxford Road, M13 9WL, Manchester, UK

    R. Gokal

  2. Division of Nephrology, Department of Medicine, MA 436 Health Services Centre, University of Missouri-Columbia, 65212, Columbia, MO, USA

    R. Khanna

  3. Academisch Medisch Centrum, Amsterdam, The Netherlands

    R. Th. Krediet

  4. Department of Internal Medicine, MA 436 Health Sciences Center, University of Missouri-Columbia, 65212, Columbia, MO, USA

    K. D. Nolph

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Boeschoten, E.W. (2000). Continuous ambulatory peritoneal dialysis. In: Gokal, R., Khanna, R., Krediet, R.T., Nolph, K.D. (eds) Textbook of Peritoneal Dialysis. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-3225-3_11

Download citation

  • DOI: https://doi.org/10.1007/978-94-017-3225-3_11

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-017-3227-7

  • Online ISBN: 978-94-017-3225-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation